<SEC-DOCUMENT>0001193125-13-363443.txt : 20130911
<SEC-HEADER>0001193125-13-363443.hdr.sgml : 20130911
<ACCEPTANCE-DATETIME>20130911074852
ACCESSION NUMBER:		0001193125-13-363443
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20130911
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20130911
DATE AS OF CHANGE:		20130911

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			AxoGen, Inc.
		CENTRAL INDEX KEY:			0000805928
		STANDARD INDUSTRIAL CLASSIFICATION:	ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
		IRS NUMBER:				411301878
		STATE OF INCORPORATION:			MN
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36046
		FILM NUMBER:		131089968

	BUSINESS ADDRESS:	
		STREET 1:		13859 PROGRESS BLVD.
		STREET 2:		SUITE 100
		CITY:			ALACHUA
		STATE:			FL
		ZIP:			32615
		BUSINESS PHONE:		(386) 462-6817

	MAIL ADDRESS:	
		STREET 1:		13859 PROGRESS BLVD.
		STREET 2:		SUITE 100
		CITY:			ALACHUA
		STATE:			FL
		ZIP:			32615

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	LECTEC CORP /MN/
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d596490d8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<HTML><HEAD>
<TITLE>Form 8-K</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>UNITED STATES </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>SECURITIES AND EXCHANGE COMMISSION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Washington, D.C. 20549 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>Form 8-K
</B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Current Report </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Pursuant
to Section&nbsp;13 or 15(d) </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>of the Securities Exchange Act of 1934 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Date of Report (Date of earliest event reported):&nbsp;September&nbsp;11, 2013 </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman" ALIGN="center"><B>AXOGEN, INC. </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Exact
name of registrant as specified in its charter) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD WIDTH="34%"></TD>
<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"><B>Minnesota</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>1-36046</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>41-1301878</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(State or other jurisdiction</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>of incorporation)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Commission</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>File Number</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(IRS Employer</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Identification No.)</B></P></TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="50%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>13859 Progress Boulevard, Suite 100,</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Alachua, Florida</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><B>32615</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" ALIGN="center"><B>(Address of Principal Executive Offices)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>(Zip Cope)</B></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Registrant&#146;s telephone number, including area code (386) 462-6800 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Former name or former address if changed since last report,) </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the
following provisions: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></TD>
<TD ALIGN="left" VALIGN="top">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></TD>
<TD ALIGN="left" VALIGN="top">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></TD>
<TD ALIGN="left" VALIGN="top">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></TD>
<TD ALIGN="left" VALIGN="top">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) </TD></TR></TABLE> <P STYLE="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Item&nbsp;8.01 Other Information </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On September&nbsp;11, 2013, AxoGen, Inc. (the &#147;Company&#148;) issued a press release announcing that the underwriters of its recent public offering of
common stock have exercised their option to purchase an additional 184,332 shares of common stock. In connection with the offering, the Company has now received aggregate gross proceeds of approximately $18.6 million, excluding deductions for
underwriting discounts and commissions and estimated expenses. JMP Securities LLC acted as the sole book-running manager in the offering and Ladenburg Thalmann&nbsp;&amp; Co. Inc., acted as co-manager. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A copy of the press release is filed herewith as Exhibit 99.1. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Item&nbsp;9.01. Financial Statements and Exhibits </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) Exhibits </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD></TD>
<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD WIDTH="90%"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE="border-bottom:1.00pt solid #000000; width:37.30pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B></B>Exhibit&nbsp;No.<B></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1.00pt solid #000000; width:37.25pt; font-size:8pt; font-family:Times New Roman"><B></B>Description<B></B></P></TD></TR>


<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">AxoGen, Inc. press release, dated September 11, 2013.</TD></TR>
</TABLE>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SIGNATURE </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="48%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD VALIGN="bottom"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="3">AXOGEN, INC.</TD></TR>


<TR>
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date: September&nbsp;11, 2013</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">By:</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">/s/ Gregory G. Freitag</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">Gregory G. Freitag</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">Chief Financial Officer</TD></TR>
</TABLE>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EXHIBIT INDEX </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD></TD>
<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD WIDTH="90%"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE="border-bottom:1.00pt solid #000000; width:37.30pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B></B>Exhibit&nbsp;No.<B></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1.00pt solid #000000; width:37.25pt; font-size:8pt; font-family:Times New Roman"><B></B>Description<B></B></P></TD></TR>


<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">AxoGen, Inc. press release, dated September 11, 2013.</TD></TR>
</TABLE>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>d596490dex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.1 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g596490g09k65.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AxoGen, Inc. Announces Exercise of Over-Allotment Option </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><I>Exercise follows public offering and generates $18.6 million in proceeds </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ALACHUA, FL &#150; September&nbsp;11, 2013 &#150; AxoGen, Inc. (NASDAQ: AXGN), a leading regenerative medicine company focused on the commercialization of
proprietary products and technologies for peripheral nerve reconstruction and regeneration, today announced that the underwriters of its recent public offering of common stock have exercised their option to purchase an additional 184,332 shares. The
total gross proceeds to AxoGen from this offering, including from the exercise of the over-allotment option, are expected to be $18.6 million, excluding deductions for underwriting discounts and commissions and estimated expenses. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">AxoGen will use the net proceeds from the offering to expand product commercialization and marketing efforts for its portfolio of peripheral nerve repair
products (Avance<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP> Nerve Graft, AxoGuard<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP> Nerve Connector and AxoGuard<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP> Nerve
Protector); to further develop its product pipeline; and for general working capital purposes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A registration statement relating to these securities has
been declared effective by the SEC. The registration statement may be accessed through the SEC&#146;s website at <U>www.sec.gov</U>.&nbsp;JMP Securities LLC acted as the sole book-running manager in the offering and Ladenburg Thalmann&nbsp;&amp; Co.
Inc. acted as co-manager.&nbsp;Copies of the final prospectus relating to this offering may be obtained from JMP Securities LLC, 600 Montgomery Street, 10th Floor, San Francisco, California 94111, Attention: Prospectus Department,
(415)&nbsp;835-8985. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About AxoGen, Inc. </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">AxoGen
(NASDAQ: AXGN) is a leading regenerative medicine company dedicated to advancing the science and commercialization of peripheral nerve repair solutions. The Company&#146;s innovative approach to regenerative medicine has resulted in first-in-class
products that we believe will define their product categories. AxoGen&#146;s products offer a full suite of surgical nerve repair solutions including Avance<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP> Nerve Graft, the only
off-the-shelf commercially available processed nerve allograft for bridging severed nerves without the comorbidities associated with a second surgical site, AxoGuard<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP> Nerve Connector, a
porcine submucosa ExtraCellular Matrix (ECM) coaptation aid for tensionless repair of severed nerves, and AxoGuard<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP> Nerve Protector, a porcine submucosa ECM product used to wrap and protect
injured peripheral nerves and reinforce the nerve reconstruction while preventing soft tissue attachments. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">AxoGuard<SUP
STYLE="font-size:85%; vertical-align:top">&reg;</SUP> Nerve Connector and AxoGuard<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP> Nerve Protector are manufactured in the United States by Cook Biotech Incorporated, West Lafayette, Indiana,
and are distributed exclusively by AxoGen.&nbsp;AxoGen is the parent of its wholly owned operating subsidiary, AxoGen Corporation. AxoGen&#146;s principal executive office and operations are located in Alachua, FL. To receive email alerts directly
from AxoGen, please click here <U>www.axogeninc.com/emailalerts.html</U>. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Cautionary Statements Concerning Forward-Looking Statements </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This Press Release contains &#147;forward-looking&#148; statements as defined in the Private Securities Litigation Reform Act of 1995. These statements are
based on management&#146;s current expectations or predictions of future conditions, events or results based on various assumptions and management&#146;s estimates of trends and economic factors in the markets in which we are active, as well as our
business plans. Words such as &#147;expects&#148;, &#147;anticipates&#148;, &#147;intends&#148;, &#147;plans&#148;, &#147;believes&#148;, &#147;seeks&#148;, &#147;estimates&#148;, &#147;projects&#148;, &#147;forecasts&#148;, &#147;continue&#148;,
&#147;may&#148;, &#147;should&#148;, &#147;will&#148; variations of such words and similar expressions are intended to identify such forward-looking statements. The forward-looking statements may include, without limitation, statements regarding
product commercialization and </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
marketing efforts for its portfolio of peripheral nerve repair products, Avance<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP> Nerve Graft, AxoGuard<SUP
STYLE="font-size:85%; vertical-align:top">&reg;</SUP> Nerve Connector and AxoGuard<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP> Nerve Protector, product development, financial performance, sales growth, product adoption, market
awareness of our products, data validation and our ability to maintain the listing of our common stock on a national securities exchange. The forward-looking statements are subject to risks and uncertainties, which may cause results to differ
materially from those set forth in the statements. Forward-looking statements in this release should be evaluated together with the many uncertainties that affect AxoGen&#146;s business and its market, particularly those discussed in the risk
factors and cautionary statements in AxoGen&#146;s filings with the Securities and Exchange Commission. Forward-looking statements are not guarantees of future performance, and actual results may differ materially from those projected. The
forward-looking statements are representative only as of the date they are made, and AxoGen assumes no responsibility to update any forward-looking statements, whether as a result of new information, future events or otherwise. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This press release does not constitute an offer to sell or a solicitation of an offer to buy, nor shall there be any sale of these securities in any state or
jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. Any offer, if at all, will be made only by means of the registration
statement and the final prospectus. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Contact: </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">AxoGen, Inc. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Greg Freitag, Chief Financial Officer </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">386.462.6856 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>InvestorRelations@AxoGenInc.com</U> </P>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g596490g09k65.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g596490g09k65.jpg
M_]C_X``02D9)1@`!`@$!+`$L``#_X0MB17AI9@``34T`*@````@`!P$2``,`
M```!``$```$:``4````!````8@$;``4````!````:@$H``,````!``(```$Q
M``(````4````<@$R``(````4````AH=I``0````!````G````,@```$L````
M`0```2P````!061O8F4@4&AO=&]S:&]P(#<N,``R,#$S.C`Y.C$Q(#`Q.C0V
M.C0Y``````.@`0`#`````0`!``"@`@`$`````0```*>@`P`$`````0```#8`
M````````!@$#``,````!``8```$:``4````!```!%@$;``4````!```!'@$H
M``,````!``(```(!``0````!```!)@("``0````!```*-`````````!(````
M`0```$@````!_]C_X``02D9)1@`!`@$`2`!(``#_[0`,061O8F5?0TT``?_N
M``Y!9&]B90!D@`````'_VP"$``P("`@)"`P)"0P1"PH+$14/#`P/%1@3$Q43
M$Q@1#`P,#`P,$0P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P!#0L+#0X-
M$`X.$!0.#@X4%`X.#@X4$0P,#`P,$1$,#`P,#`P1#`P,#`P,#`P,#`P,#`P,
M#`P,#`P,#`P,#`P,#/_``!$(`"D`@`,!(@`"$0$#$0'_W0`$``C_Q`$_```!
M!0$!`0$!`0`````````#``$"!`4&!P@)"@L!``$%`0$!`0$!``````````$`
M`@,$!08'"`D*"Q```00!`P($`@4'!@@%`PPS`0`"$0,$(1(Q!4%181,B<8$R
M!A21H;%"(R054L%B,S1R@M%#!R624_#A\6-S-1:BLH,F1)-49$7"HW0V%])5
MXF7RLX3#TW7C\T8GE*2%M)7$U.3TI;7%U>7U5F9VAI:FML;6YO8W1U=G=X>7
MI[?'U^?W$0`"`@$"!`0#!`4&!P<&!34!``(1`R$Q$@1!46%Q(A,%,H&1%*&Q
M0B/!4M'P,R1BX7*"DD-3%6-S-/$E!A:BLH,')C7"TD235*,79$55-G1EXO*S
MA,/3=>/S1I2DA;25Q-3D]*6UQ=7E]59F=H:6IK;&UN;V)S='5V=WAY>GM\?_
MV@`,`P$``A$#$0`_`/54SG-:TN<0&@22=``$B0`23`&I)7%]=Z]^T+#CTDC`
MK/T08]9P_.>1_P!I_P!UGYZEP8)994-`/FEV8.9YF&"'%+61^6/[SJYGUD]0
M.^P.95CM.U_4+P2R>[,3';^ER[/ZOZ-9S.L='>_]>=G9A)]UCW;&`^+,6BRM
MC6?V-ZQ'.MOL!,O>!#0T:-:.&L8W^;K3/KL9&]KF;OHR(F/!:4>5QQ%"Q_=-
M2_QOF<?)SV69XB`1VD.*'^)\G_=OH6#3B"IE^$]QHL:'-`>YS"#W:VPNV?V5
M;6-]4M_[%KW?1WV;/ZNX_P#?MRV"0T%SC`&I)X`69EB8Y)1OBX21;M8)"6*$
MJ$>*(EPC86NDAU9%%T^E8RR.=C@Z)_JHBC(K=E!!U&JDDDDE*247O96POL<&
M,;JYSC``\R57Q^I]-RK#5BY=%]@Y978U[O\`-8XI*;22222E))))*?_0['ZW
M]3=74WIM)AUXW7D=JYCT_P#KKO\`H+GL7"]5@NMW-I)+:F,_G+G-&ZQE,^UE
M53!^GRG?HZ5<.+;UOZP9#2XMK-KFN>.U=?L:UG\MS6*YT_.P1]8;ADEE.+16
M[%PVO@5M:UP8YON]NZW:_P"FM2'ZK%P1%R$?<G6_J_E_B.'D_7YO<R&H2G[.
M*_E]/Z7\O\I-PK<ISVAC`*:2?937,&>-SOYW(?\`\8KF1AWXG3J,*QI^VYUX
MNKQ^[&AIIKW-_,LN>_W?^8+:LS?J]TZP#I.-7E9[I]-M(#@/WG.N]S:ZVM^E
ML3_5_IM^1E.ZSGN]6U_\PX\&=/5K;_H=OZ/'_D?I?\(E+/4>(Q,(#4"7SY)_
MHZ?N_P!94.5N?`)C).7IE*'\WAQ_I^K]_P#=A^@[73L-N#@TXC3/HL#2?$\O
M=_:>LOZTYKA15TNC7(SW!A`Y#"0UW_;CO9_VXMQSFM:7.(:UHDD\`!<,SKF*
M>NOZKEM>]C01C5MVR!]"MSM[F_F&Q_\`QEBJ<M"4YRR5Q<'K_O9/T6_SF2&+
M%#$#P#)6._W,0^<_XK<^J?ZMU#/I#=[F5G1D#<:GN9[?ZVY:N']:>GY5=]A;
M92W&8+'^H!J"=L,VN=[M_L6)]6\ECOK!9:WVUY#;G`&-`7-N$_V52>WI^1UL
ML:\G`NR(W#31Y[?\%ZI^E_HE9R88Y,L^,&^&,^(?\Z/_`#6GBYF>+#C]LQHS
MGCX9>/JA+^['B]3T_P#SJP6X0R[:[:Q82*:B&[[`WZ=C&AVWTF_Z1[D_3?K/
MAY^2,4UV8]KY],61#B!NVRWZ+]O[RQPQF=];6TEH%&._8RL#VAF.V6L#?W/6
M0NIW&SZRWW4Z''#G`CQHI<]W_3]JC.#%1'"0?;.:[^3]V+*.:SW$\0,?='+\
M/#_.G].?]7^JY/5LK,^N?UF'1L>[T^FTO>&1JR*M+\RQG^'>ZS]%B[_T;/\`
MMQ0^LGU+RNCYF';]7:<K*?!>'M`<ZJVLL-;O68VIK&W;OH.1?\5]6[.S;VP;
MJ\6MM;28GU'.>X_Y]3$!EWUKQ?K'B=%S>KVVW/NI.1Z%FYH:X^M97[ZJW;OL
M['?V%2=1[+K7URZ;T4U8][+,CJ%C6N.'0`Y[=W'J:[6;OS/\(]1Z+]=>E]6J
MR2&68U^'6ZZ['M`W>FSZ=E;FG:[;]!_[BXGZO7=<ZCU_,ZUTK&HR\R7VD9+B
MUE;;B65>FX>[U&45>@S_`()%R,/K&*>M]<SAC,=DXUE#FX]K;`+<E].-L#&R
MYOM99]-!3T`_QG]%.*;OLV0+26BK'<&!SI&YUFYMCJZZZ_H[K'?3_FUN_5WZ
MQ8G7\1^1CL?2^E_IW4V1N:Z`\>YI<Q['-<N)Z757@_XN^J9I8/5SWNI8XC4L
MW-PZVC^H[UK&K?\`\6V**N@/R(URLBQ\_P`ED4-_\])*?__1[;#H?T>^RZZI
MQH??D>I8P%^UKS79C6%C`Y_I[&/K?_H[%5R^E]!S+[,FBS(<;';K*Z&DM+G<
M^ZRO97O=_P`(NI3'D?'^"N`YO<](/N5ZN`^FK_2XHN=(<O[7J,1BXO1[D;EQ
M5^@8R<'I_P!7ZS'J4#&Q?SJ)W6W?^'+_`/0_]U6?H_\`2K>``$#A.DH<_N<7
MK^G\I>KB_O-GE?:X/U7UV_[CT</]QH=:Q,W,P7XN(]E;K3ML<\D>S\]K=@/T
M_H?U$W2>DU8&#7CV-99:)=8^-"YQGV[OS6_1:M!)(>Y[.G\WQ:U\W'_64?9^
M\>J_=X-.+Y/;O]%Y7*^JO4K,S(OQ[ZJF7O?`]P(99]-AVM_=1NH_5,V8^+3@
M/96[':YKWV3+B8>+/9/O]1=(DK/]+O'M_5V_=_3_`,%I?T"LMW_6OBOY_P#)
M_P"'\SS5_P!7^L5Y_P"T<"^IF18)M!F&O<T-OV;F/WUO=[_<U6^C?5X83KLC
M,L&3E9`+7F/:`[W6CW?3]5WTWK:23,GWCVM>'AX1Q<->Y[?Z'%_49,/W3WO3
MQ<7%+AX^+VO=_3X/T/<?/7?XOOK!T[.=;T'/9529;78Y[Z[6UD[O1MV,M9>Q
MBT>C_47)Z=UG"ZG;EC*?4+K,U[]VY]UC376:@[?[&-L?ZEEMOJ6+L4E3=%X&
MKZD_6CI&7D#ZOY]-6+D^S=9(L;7)=6QX]*YOJ4[W,KOK1+/\7=^/T+]G]/OJ
M.9DWLOSLFT.:'MK#_2HK97ZCME=K]_O_`.$L7=))*>2ZE]4>HW_5;IW0L6ZE
MC\5S'Y#W[]KBT/<[T]K2[W7V;_>M#IW1NI=-Z5TW`Q[V`XK0,DMT:YQ.^QS=
MPW.KWN>MU))3_]G_[1`R4&AO=&]S:&]P(#,N,``X0DE-!"4``````!``````
M````````````````.$))30/M```````0`2P````!``$!+`````$``3A"24T$
M)@``````#@`````````````_@```.$))300-```````$````'CA"24T$&0``
M````!````!XX0DE-`_,```````D```````````$`.$))300*```````!```X
M0DE-)Q````````H``0`````````!.$))30/U``````!(`"]F9@`!`&QF9@`&
M```````!`"]F9@`!`*&9F@`&```````!`#(````!`%H````&```````!`#4`
M```!`"T````&```````!.$))30/X``````!P``#_____________________
M________`^@`````_____________________________P/H`````/______
M______________________\#Z`````#_____________________________
M`^@``#A"24T$"```````$`````$```)````"0``````X0DE-!!X```````0`
M````.$))300:``````.+````!@``````````````-@```*<````K`%``<@!E
M`',`<P`@`%(`90!L`&4`80!S`&4`(``R`#``,0`S`"``,``Y`"``,0`P`"``
M3P!V`&4`<@`@`$$`;`!L`&\`=`!M`&4`;@!T`"``=@`T`#$````!````````
M``````````````````$``````````````*<````V````````````````````
M``$`````````````````````````$`````$```````!N=6QL`````@````9B
M;W5N9'-/8FIC`````0```````%)C=#$````$`````%1O<"!L;VYG````````
M``!,969T;&]N9P``````````0G1O;6QO;F<````V`````%)G:'1L;VYG````
MIP````9S;&EC97-6;$QS`````4]B:F,````!```````%<VQI8V4````2````
M!W-L:6-E241L;VYG``````````=G<F]U<$E$;&]N9P`````````&;W)I9VEN
M96YU;0````Q%4VQI8V5/<FEG:6X````-875T;T=E;F5R871E9`````!4>7!E
M96YU;0````I%4VQI8V54>7!E`````$EM9R`````&8F]U;F1S3V)J8P````$`
M``````!28W0Q````!`````!4;W`@;&]N9P``````````3&5F=&QO;F<`````
M`````$)T;VUL;VYG````-@````!29VAT;&]N9P```*<````#=7)L5$585```
M``$```````!N=6QL5$585`````$```````!-<V=E5$585`````$```````9A
M;'1486=415A4`````0``````#F-E;&Q497AT27-(5$U,8F]O;`$````(8V5L
M;%1E>'1415A4`````0``````"6AO<GI!;&EG;F5N=6T````/15-L:6-E2&]R
M>D%L:6=N````!V1E9F%U;'0````)=F5R=$%L:6=N96YU;0````]%4VQI8V56
M97)T06QI9VX````'9&5F875L=`````MB9T-O;&]R5'EP965N=6T````115-L
M:6-E0D=#;VQO<E1Y<&4`````3F]N90````ET;W!/=71S971L;VYG````````
M``IL969T3W5T<V5T;&]N9P`````````,8F]T=&]M3W5T<V5T;&]N9P``````
M```+<FEG:'1/=71S971L;VYG```````X0DE-!!0```````0````".$))300,
M``````I0`````0```(`````I```!@```/8````HT`!@``?_8_^``$$I&248`
M`0(!`$@`2```_^T`#$%D;V)E7T--``'_[@`.061O8F4`9(`````!_]L`A``,
M"`@("0@,"0D,$0L*"Q$5#PP,#Q48$Q,5$Q,8$0P,#`P,#!$,#`P,#`P,#`P,
M#`P,#`P,#`P,#`P,#`P,#`P,`0T+"PT.#1`.#A`4#@X.%!0.#@X.%!$,#`P,
M#!$1#`P,#`P,$0P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`S_P``1"``I
M`(`#`2(``A$!`Q$!_]T`!``(_\0!/P```04!`0$!`0$``````````P`!`@0%
M!@<("0H+`0`!!0$!`0$!`0`````````!``(#!`4&!P@)"@L0``$$`0,"!`(%
M!P8(!0,,,P$``A$#!"$2,05!46$3(G&!,@84D:&Q0B,D%5+!8C,T<H+10P<E
MDE/PX?%C<S46HK*#)D235&1%PJ-T-A?25>)E\K.$P]-UX_-&)Y2DA;25Q-3D
M]*6UQ=7E]59F=H:6IK;&UN;V-T=79W>'EZ>WQ]?G]Q$``@(!`@0$`P0%!@<'
M!@4U`0`"$0,A,1($05%A<2(3!3*!D12AL4(CP5+1\#,D8N%R@I)#4Q5C<S3Q
M)086HK*#!R8UPM)$DU2C%V1%539T9>+RLX3#TW7C\T:4I(6TE<34Y/2EM<75
MY?569G:&EJ:VQM;F]B<W1U=G=X>7I[?'_]H`#`,!``(1`Q$`/P#U5,YS6M+G
M$!H$DG0`!(D`$DP!J25Q?7>O?M"PX])(P*S]$&/6</SGD?\`:?\`=9^>I<&"
M665#0#YI=F#F>9A@AQ2UD?EC^\ZN9]9/4#OL#F58[3M?U"\$LGNS$QV_I<NS
M^K^C6<SK'1WO_7G9V82?=8]VQ@/BS%HLK8UG]C>L1SK;[`3+W@0T-&C6CAK&
M-_FZTSZ[&1O:YF[Z,B)CP6E'E<<10L?W34O\;YG'R<]EF>(@$=I#BA_B?)_W
M;Z%@TX@J9?A/<:+&AS0'N<P@]VML+MG]E6UC?5+?^Q:]WT=]FS^KN/\`W[<M
M@D-!<XP!J2>`%F98F.24;XN$D6[6"0EBA*A'BB)<(V%KI(=611=/I6,LCG8X
M.B?ZJ(HR*W900=1JI))))2DE%[V5L+['!C&ZN<XP`/,E5\?J?3<JPU8N71?8
M.65V->[_`#6.*2FTDDDDI22222G_T.Q^M_4W5U-Z;28=>-UY':N8]/\`ZZ[_
M`*"Y[%PO58+K=S:22VIC/YRYS1NL93/M954P?I\IWZ.E7#BV];^L&0TN+:S:
MYKGCM77[&M9_+<UBN=/SL$?6&X9)93BT5NQ<-KX%;6M<&.;[O;NMVO\`IK4A
M^JQ<$1<A'W)UOZOY?XCAY/U^;W,AJ$I^SBOY?3^E_+_*3<*W*<]H8P"FDGV4
MUS!GC<[^=R'_`/&*YD8=^)TZC"L:?MN=>+J\?NQH:::]S?S++GO]W_F"VK,W
MZO=.L`Z3C5Y6>Z?3;2`X#]YSKO<VNMK?I;$_U?Z;?D93NLY[O5M?_,./!G3U
M:V_Z';^CQ_Y'Z7_")2SU'B,3"`U`E\^2?Z.G[O\`65#E;GP"8R3EZ92A_-X<
M?Z?J_?\`W8?H.UT[#;@X-.(TSZ+`TGQ/+W?VGK+^M.:X45=+HUR,]P80.0PD
M-=_VX[V?]N+<<YK6ESB&M:))/``7#,ZYBGKK^JY;7O8T$8U;=L@?0K<[>YOY
MAL?_`,98JG+0E.<LE<7!Z_[V3]%O\YDABQ0Q`\`R5CO]S$/G/^*W/JG^K=0S
MZ0W>YE9T9`W&I[F>W^MN6KA_6GI^57?86V4MQF"Q_J`:@G;#-KG>[?[%B?5O
M)8[ZP66M]M>0VYP!C0%S;A/]E4GMZ?D=;+&O)P+LB-PTT>>W_!>J?I?Z)6<F
M&.3+/C!OAC/B'_.C_P`UIXN9GBPX_;,:,YX^&7CZH2_NQXO4]/\`\ZL%N$,N
MVNVL6$BFHAN^P-^G8QH=M])O^D>Y/TWZSX>?DC%-=F/:^?3%D0X@;MLM^B_;
M^\L<,9G?6UM):!1COV,K`]H9CMEK`W]SUD+J=QL^LM]U.AQPYP(\:*7/=_T_
M:HS@Q41PD'VSFN_D_=BRCFL]Q/$#'W1R_#P_SI_3G_5_JN3U;*S/KG]9AT;'
MN]/IM+WAD:LBK2_,L9_AWNL_18N_]&S_`+<4/K)]2\KH^9AV_5VG*RGP7A[0
M'.JMK+#6[UF-J:QMV[Z#D7_%?5NSLV]L&ZO%K;6TF)]1SGN/^?4Q`9=]:\7Z
MQXG1<WJ]MMS[J3D>A9N:&N/K65^^JMV[[.QW]A4G4>RZU]<NF]%-6/>RS(ZA
M8UKCAT`.>W=QZFNUF[\S_"/4>B_77I?5JLDAEF-?AUNNNQ[0-WIL^G96YIVN
MV_0?^XN)^KUW7.H]?S.M=*QJ,O,E]I&2XM96VXEE7IN'N]1E%7H,_P""1<C#
MZQBGK?7,X8S'9.-90YN/:VP"W)?3C;`QLN;[66?304]`/\9_13BF[[-D"TEH
MJQW!@<Z1N=9N;8ZNNNOZ.ZQWT_YM;OU=^L6)U_$?D8['TOI?Z=U-D;FN@/'N
M:7,>QS7+B>EU5X/^+OJF:6#U<][J6.(U+-S<.MH_J.]:QJW_`/%MBBKH#\B-
M<K(L?/\`)9%#?_/22G__T>VPZ']'OLNNJ<:'WY'J6,!?M:\UV8UA8P.?Z>QC
MZW_Z.Q5<OI?0<R^S)HLR'&QVZRNAI+2YW/NLKV5[W?\`"+J4QY'Q_@K@.;W/
M2#[E>K@/IJ_TN*+G2'+^UZC$8N+T>Y&Y<5?H&,G!Z?\`5^LQZE`QL7\ZB=UM
MW_AR_P#T/_=5GZ/_`$JW@`!`X3I*'/[G%Z_I_*7JXO[S9Y7VN#]5]=O^X]'#
M_<:'6L3-S,%^+B/96ZT[;'/)'L_/:W8#]/Z']1-TGI-6!@UX]C666B76/C0N
M<9]N[\UOT6K022'N>SI_-\6M?-Q_UE'V?O'JOW>#3B^3V[_1>5ROJKU*S,R+
M\>^JIE[WP/<"&6?38=K?W4;J/U3-F/BTX#V5NQVN:]]DRXF'BSV3[_472)*S
M_2[Q[?U=OW?T_P#!:7]`K+=_UKXK^?\`R?\`A_,\U?\`5_K%>?\`M'`OJ9D6
M";09AKW-#;]FYC]];W>_W-5OHWU>&$Z[(S+!DY60"UYCV@.]UH]WT_5=]-ZV
MDDS)]X]K7AX>$<7#7N>W^AQ?U&3#]T][T\7%Q2X>/B]KW?T^#]#W'SUW^+[Z
MP=.SG6]!SV54F6UV.>^NUM9.[T;=C+67L8M'H_U%R>G=9PNIVY8RGU"ZS->_
M=N?=8TUUFH.W^QC;'^I9;;ZEB[%)4W1>!J^I/UHZ1EY`^K^?35BY/LW62+&U
MR75L>/2N;ZE.]S*[ZT2S_%W?C]"_9_3[ZCF9-[+\[)M#FA[:P_TJ*V5^H[97
M:_?[_P#A+%W222GDNI?5'J-_U6Z=T+%NI8_%<Q^0]^_:XM#W.]/:TN]U]F_W
MK0Z=T;J73>E=-P,>]@.*T#)+=&N<3OL<W<-SJ][GK=224__9.$))300A````
M``!5`````0$````/`$$`9`!O`&(`90`@`%``:`!O`'0`;P!S`&@`;P!P````
M$P!!`&0`;P!B`&4`(`!0`&@`;P!T`&\`<P!H`&\`<``@`#<`+@`P`````0`X
M0DE-!`8```````<`"`````$!`/_A$DAH='1P.B\O;G,N861O8F4N8V]M+WAA
M<"\Q+C`O`#P_>'!A8VME="!B96=I;CTG[[N_)R!I9#TG5S5-,$UP0V5H:4AZ
M<F53>DY48WIK8SED)S\^"CP_861O8F4M>&%P+69I;'1E<G,@97-C/2)#4B(_
M/@H\>#IX87!M971A('AM;&YS.G@])V%D;V)E.FYS.FUE=&$O)R!X.GAA<'1K
M/2=835`@=&]O;&MI="`R+C@N,BTS,RP@9G)A;65W;W)K(#$N-2<^"CQR9&8Z
M4D1&('AM;&YS.G)D9CTG:'1T<#HO+W=W=RYW,RYO<F<O,3DY.2\P,B\R,BUR
M9&8M<WEN=&%X+6YS(R<@>&UL;G,Z:5@])VAT='`Z+R]N<RYA9&]B92YC;VTO
M:5@O,2XP+R<^"@H@/')D9CI$97-C<FEP=&EO;B!A8F]U=#TG=75I9#IB93-E
M935B92TQ834U+3$Q93,M.39F,RUB.&8V,C4P.68U,SDG"B`@>&UL;G,Z>&%P
M34T])VAT='`Z+R]N<RYA9&]B92YC;VTO>&%P+S$N,"]M;2\G/@H@(#QX87!-
M33I$;V-U;65N=$E$/F%D;V)E.F1O8VED.G!H;W1O<VAO<#IB93-E935B8RTQ
M834U+3$Q93,M.39F,RUB.&8V,C4P.68U,SD\+WAA<$U-.D1O8W5M96YT240^
M"B`\+W)D9CI$97-C<FEP=&EO;CX*"CPO<F1F.E)$1CX*/"]X.GAA<&UE=&$^
M"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M(`H\/WAP86-K970@96YD/2=W)S\^_^(,6$E#0U]04D]&24Q%``$!```,2$QI
M;F\"$```;6YT<E)'0B!865H@!\X``@`)``8`,0``86-S<$U31E0`````245#
M('-21T(```````````````$``/;6``$`````TRU(4"`@````````````````
M```````````````````````````````````````````````18W!R=````5``
M```S9&5S8P```80```!L=W1P=````?`````48FMP=````@0````4<EA96@``
M`A@````49UA96@```BP````48EA96@```D`````49&UN9````E0```!P9&UD
M9````L0```"(=G5E9````TP```"&=FEE=P```]0````D;'5M:0```_@````4
M;65A<P``!`P````D=&5C:```!#`````,<E120P``!#P```@,9U120P``!#P`
M``@,8E120P``!#P```@,=&5X=`````!#;W!Y<FEG:'0@*&,I(#$Y.3@@2&5W
M;&5T="U086-K87)D($-O;7!A;GD``&1E<V,`````````$G-21T(@245#-C$Y
M-C8M,BXQ```````````````2<U)'0B!)14,V,3DV-BTR+C$`````````````
M`````````````````````````````````````````````````````%A96B``
M``````#S40`!`````1;,6%E:(`````````````````````!865H@````````
M;Z(``#CU```#D%A96B````````!BF0``MX4``!C:6%E:(````````"2@```/
MA```ML]D97-C`````````!9)14,@:'1T<#HO+W=W=RYI96,N8V@`````````
M`````!9)14,@:'1T<#HO+W=W=RYI96,N8V@`````````````````````````
M````````````````````````````````````9&5S8P`````````N245#(#8Q
M.38V+3(N,2!$969A=6QT(%)'0B!C;VQO=7(@<W!A8V4@+2!S4D="````````
M```````N245#(#8Q.38V+3(N,2!$969A=6QT(%)'0B!C;VQO=7(@<W!A8V4@
M+2!S4D="`````````````````````````````&1E<V,`````````+%)E9F5R
M96YC92!6:65W:6YG($-O;F1I=&EO;B!I;B!)14,V,3DV-BTR+C$`````````
M`````"Q2969E<F5N8V4@5FEE=VEN9R!#;VYD:71I;VX@:6X@245#-C$Y-C8M
M,BXQ``````````````````````````````````!V:65W```````3I/X`%%\N
M`!#/%``#[<P`!!,+``-<G@````%865H@``````!,"58`4````%<?YVUE87,`
M`````````0````````````````````````*/`````G-I9R``````0U)4(&-U
M<G8````````$``````4`"@`/`!0`&0`>`",`*``M`#(`-P`[`$``10!*`$\`
M5`!9`%X`8P!H`&T`<@!W`'P`@0"&`(L`D`"5`)H`GP"D`*D`K@"R`+<`O`#!
M`,8`RP#0`-4`VP#@`.4`ZP#P`/8`^P$!`0<!#0$3`1D!'P$E`2L!,@$X`3X!
M10%,`5(!60%@`6<!;@%U`7P!@P&+`9(!F@&A`:D!L0&Y`<$!R0'1`=D!X0'I
M`?(!^@(#`@P"%`(=`B8"+P(X`D$"2P)4`ET"9P)Q`GH"A`*.`I@"H@*L`K8"
MP0++`M4"X`+K`O4#``,+`Q8#(0,M`S@#0P-/`UH#9@-R`WX#B@.6`Z(#K@.Z
M`\<#TP/@`^P#^00&!!,$(`0M!#L$2`15!&,$<01^!(P$F@2H!+8$Q`33!.$$
M\`3^!0T%'`4K!3H%2058!6<%=P6&!98%I@6U!<4%U07E!?8&!@86!B<&-P9(
M!ED&:@9[!HP&G0:O!L`&T0;C!O4'!P<9!RL'/0=/!V$'=`>&!YD'K`>_!]('
MY0?X"`L('P@R"$8(6@AN"(((E@BJ"+X(T@CG"/L)$`DE"3H)3PED"7D)CPFD
M";H)SPGE"?L*$0HG"CT*5`IJ"H$*F`JN"L4*W`KS"PL+(@LY"U$+:0N`"Y@+
ML`O("^$+^0P2#"H,0PQ<#'4,C@RG#,`,V0SS#0T-)@U`#5H-=`V.#:D-PPW>
M#?@.$PXN#DD.9`Y_#IL.M@[2#NX/"0\E#T$/7@]Z#Y8/LP_/#^P0"1`F$$,0
M81!^$)L0N1#7$/41$Q$Q$4\1;1&,$:H1R1'H$@<2)A)%$F02A!*C$L,2XQ,#
M$R,30Q-C$X,3I!/%$^44!A0G%$D4:A2+%*T4SA3P%1(5-!56%7@5FQ6]%>`6
M`Q8F%DD6;!:/%K(6UA;Z%QT701=E%XD7KA?2%_<8&QA`&&48BABO&-48^AD@
M&449:QF1&;<9W1H$&BH:41IW&IX:Q1KL&Q0;.QMC&XH;LAO:'`(<*AQ2''L<
MHQS,'/4='AU''7`=F1W#'>P>%AY`'FH>E!Z^'ND?$Q\^'VD?E!^_'^H@%2!!
M(&P@F"#$(/`A'"%((74AH2'.(?LB)R)5(H(BKR+=(PHC."-F(Y0CPB/P)!\D
M321\)*LDVB4))3@E:"67)<<E]R8G)E<FAR:W)N@G&"=))WHGJR?<*`TH/RAQ
M**(HU"D&*3@I:RF=*=`J`BHU*F@JFRK/*P(K-BMI*YTKT2P%+#DL;BRB+-<M
M#"U!+78MJRWA+A8N3"Z"+K<N[B\D+UHOD2_'+_XP-3!L,*0PVS$2,4HQ@C&Z
M,?(R*C)C,ILRU#,-,T8S?S.X,_$T*S1E-)XTV#43-4TUAS7"-?TV-S9R-JXV
MZ3<D-V`WG#?7.!0X4#B,.,@Y!3E".7\YO#GY.C8Z=#JR.N\[+3MK.ZH[Z#PG
M/&4\I#SC/2(]83VA/>`^(#Y@/J`^X#\A/V$_HC_B0"-`9$"F0.=!*4%J0:Q!
M[D(P0G)"M4+W0SI#?4/`1`-$1T2*1,Y%$D5519I%WD8B1F=&JT;P1S5'>T?`
M2`5(2TB12-=)'4EC2:E)\$HW2GU*Q$L,2U-+FDOB3"I,<DRZ30)-2DV33=Q.
M)4YN3K=/`$])3Y-/W5`G4'%0NU$&45!1FU'F4C%2?%+'4Q-37U.J4_940E2/
M5-M5*%5U5<)6#U9<5JE6]U=$5Y)7X%@O6'U8RUD:66E9N%H'6E9:IEKU6T5;
ME5OE7#5<AES672==>%W)7AI>;%Z]7P]?85^S8`5@5V"J8/QA3V&B8?5B26*<
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MEHO\C&.,RHTQC9B-_XYFCLZ/-H^>D`:0;I#6D3^1J)(1DGJ2XY--D[:4()2*
ME/257Y7)EC26GY<*EW67X)A,F+B9))F0F?R::)K5FT*;KYP<G(F<]YUDG=*>
M0)ZNGQV?BY_ZH&F@V*%'H;:B)J*6HP:C=J/FI%:DQZ4XI:FF&J:+IOVG;J?@
MJ%*HQ*DWJ:FJ'*J/JP*K=:OIK%RLT*U$K;BN+:ZAKQ:OB[``L'6PZK%@L=:R
M2[+"LSBSKK0EM)RU$[6*M@&V>;;PMVBWX+A9N-&Y2KG"NCNZM;LNNZ>\(;R;
MO16]C[X*OH2^_[]ZO_7`<,#LP6?!X\)?PMO#6,/4Q%'$SL5+Q<C&1L;#QT''
MO\@]R+S).LFYRCC*M\LVR[;,-<RUS37-M<XVSK;/-\^XT#G0NM$\T;[2/]+!
MTT33QM1)U,O53M71UE76V-=<U^#89-CHV6S9\=IVVOO;@-P%W(K=$-V6WAS>
MHM\IWZ_@-N"]X43AS.)3XMOC8^/KY'/D_.6$Y@WFEN<?YZGH,NB\Z4;IT.I;
MZN7K<.O[[(;M$>V<[BCNM.]`[\SP6/#E\7+Q__*,\QGSI_0T],+U4/7>]FWV
M^_>*^!GXJ/DX^<?Z5_KG^W?\!_R8_2G]NOY+_MS_;?___^X`#D%D;V)E`&1`
M`````?_;`(0``0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0("`@("`@("`@("`P,#`P,#`P,#`P$!`0$!`0$!`0$!`@(!`@(#
M`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#
M`P,#_\``$0@`-@"G`P$1``(1`0,1`?_=``0`%?_$`:(````&`@,!````````
M``````<(!@4$"0,*`@$`"P$```8#`0$!````````````!@4$`P<""`$)``H+
M$``"`0,$`0,#`@,#`P(&"74!`@,$$042!B$'$R(`"#$403(C%0E10A9A)#,7
M4G&!&&*1)4.AL?`F-'(*&<'1-2?A4S:"\9*B1%1S148W1V,H5597&K+"TN+R
M9(-TDX1EH[/#T^,I.&;S=2HY.DA)2EA96F=H:6IV=WAY>H6&AXB)BI25EI>8
MF9JDI::GJ*FJM+6VM[BYNL3%QL?(R<K4U=;7V-G:Y.7FY^CIZO3U]O?X^?H1
M``(!`P($!`,%!`0$!@8%;0$"`Q$$(1(%,08`(A-!40<R811Q"$*!(Y$54J%B
M%C,)L23!T4-R\!?A@C0EDE,88T3QHK(F-1E4-D5D)PIS@Y-&=,+2XO)59756
M-X2%H[/#T^/S*1J4I+3$U.3TE:6UQ=7E]2A'5V8X=H:6IK;&UN;V9W>'EZ>W
MQ]?G]TA8:'B(F*BXR-CH^#E)66EYB9FIN<G9Z?DJ.DI::GJ*FJJZRMKJ^O_:
M``P#`0`"$0,1`#\`W^/?NO=>]^Z]TWY7+8S!8VNS.:R%%B<3C*6:MR.3R-3#
M1T-#1TZ&2>IJJJ=TA@@B1269B`![>MK:XO+B&UM('EN9&"JB@LS,<``#))/`
M#I->WMIMUI<7]_<QPV4*%WD=@J(JBI9F)```R23U6#OK^8%N/L7-Y;9GPWV9
MB-]1[?+IO+N_L:K?:_36S(&#A*YLG55./?)(%1G0N\7DT_M13`W]Y#[/[)6&
MPVEKNWNMNLMF9_[#;[5?&OYS_#H`;1Y`T!I7N9.L0N8OO,[KS3N%[L/L1L,&
MXK:_[E;M?,;?:[4'@YD9D,@P2*LNJG8D@/0'T^[N@=W5RO\`)O\`F/[CWMGY
MIKU>T^IMT9?K7JG&3ZM,M#32[5Q(JLC2*?2)YJR%F47('L7OM?.VV0E?;WV%
M@M+(#MFO84N[QQY,1,]%;STJA`X=1Y%OGMIOER&]W/O576X;DS=UMMMQ)8;=
M&?-%-O'J=?(.TJDC)IU8/UU\=.H*/%X;=W2W8?8^/H:N.&OQFX=N]O[HWA@L
MW"#=#78_<N7W-MW,TCL")$:#5]0"C<B$-]Y[YHFN;O;.;-CL'F4E7BEL88)(
MS_1:)(I4;T(;\B.LG>5O:WD>"SL-[Y!YGW6*W<!XYH-SN+J&4>6M)Y9X)5/!
M@4KQ%5.0:VB2KCI($KYH:BL2-5J*BGA:GAGD7@RI`TDS0B2U].MM)-@2/<;2
MF,R.85*Q$X!-2!Z5H*T]:#J9H%G6&-;EU:<#N*C2"?4"II7TJ:>O4KVWT]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW7__0W^/?NO=(SL+L':'5FSL]OW?>:I-O[7VY0R5V3R58X551
M!:*GIX[ZZJNJY2(X(4!DEE8*H)/LUV/9-TYCW6RV79K1I]QN'"HBC]I)\E49
M9CA0"3CHAYGYFV/D[8MRYDYCW!+;9[2,O)(Q\AP51Q9V-%114LQ``J>M9_Y2
M?-/<'R=S$C[DES>T_CWBL@TFU^K,34K1;D[(JJ%_VZ[<^2C5TI:7R`&61O)3
MT*DQP)-57D7H%[=>TUE[>6JC;TANN>9$_6O'&J*T5OPPH?B:G`"C2'N<I'13
MR6]X??[<O=V^=MU>XLO;&&2MOMT;:)[]DX/<2#"K7XF.I(1VQK)-5@27>79^
M[-ZXO%[:K:BEP^R-OO,VW.O]N0?PK9^#,S`R3QXV-FDRV5FTCS9"ODJJZ=A=
MI?P)=VGEW;-HN+F_A1I=XG`\6YE.N>2G`%SA$'X8HPD:^2]8^[]S?O7,%I9[
M3<2I!R];$^!90#P[6&O$B,&LDA_%-,9)7.2_ET'OL]Z"_5TW\G#M/.4N^>R>
MF*JOJ9]KY+;4>^\)C9'+TV*SF.R5+C,O)1(QM3)EJ/(Q-,JV5Y*=6(N23B7]
MZKERSDV?8.;(X5&XQW!MY'&"\;(70-ZZ&5@I/`,1PZS\^XESEN,/,7-?(4UR
M[;/+:"\BC)JL<R2+'*4'X1(KJ6`P2@-*U/6P3[PBZZ:]>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W
M[KW7_]'?RJ:BGHZ>>KJYHJ:EI89:BIJ)W6*&"G@1I9III7(2.**-2S,2``+G
MW>.-Y72*-"TC$``9))P`!YDGATW++'!%)--($A12S,30``5)).``,DG@.M5[
MY]_,JN^3&_SMG:=74T_2^QLA/!MZA62:&+>67IY&@J=XY6G#A986TLF-C=;P
MT[&2P>5K='O93VIA]OMD_>&YQ*W-EY&#*U`3`AR($/D>!E(^)J+P4=<;_O*^
M_%Q[M<S':=EG=>0=NE(@2I`NI5-&NI!7(P1`".U"6PSFA#:2ES.YLM18O&4-
M?FLQD'BH<7BL92SUM9-8Z8*.@H:9))/%%JX55TH+L;<GW,TLEIMUK-<7$R0V
MD8+.[L%4>K,QH*GU)J>`\AUC?!#?[O?6]G9V\MQ?RD)''&I=CZ*B+4T'H!0<
M3YGI8YG8E!M"22BWENK&TN?IYO%5[4VL(=UY:@('KBRN6I*N':V-K8F]+TXK
M*B:-@0ZJ1;V56F]3[HJS;3MDC6+"JS35A1OFB$&9U/DVA5(R"1T>W_+EOL;/
M!OV\PIN2M1K:WI<R)ZB256%NCC@4$KLIPP!QTZP]9TN?ZWWGV7LO+9&NQ_7&
M0VU2;WPF>QM-093'4&[ZJJQ^"S^.K,?6UN/R6-?*4AIIXCXJB!W1]+H253-S
M#+9;_M/+^[VL:3W\<K6\D;ED9H`&DC=6561M!UJ>Y6`(J"*%:G*,.Y\J[]S9
MR_>RRVVU2VZW<,T:I(B7+,D,T;(SI(AD4QNO:Z$J:,I)%F_\FK9D^0[4[<W^
MT9^RVULK$;7CEMZ?XEN?+G(L@)%B4H<`2;?36/>/GWK=V2#ESE?9`WZUQ=O,
M1_0B31_QZ3^1ZRY^X=L,ESSESOS*5_0M-OCMP?Z=Q)KI^20G]HZV'/>#/74'
MHI/R\^6NV/B7LW;VX\Q@*O=V:W5G3AL%MB@R-/BZFJAI:<U>7RDE94P5,<5)
MC(6C#>@EI)D4?7W)OMA[9;C[F;M?6%K>K:VEM#XDDS*7`).E$"@@EG-:9P%)
MZA/WO][-H]E-AVS=;[;7OK^\N/"AMT=8V8*NJ20LP8!8QIKC)90./2'^''S@
MQ?RYR>_<71=?9#8TVQZ'`USM79ZDS0R<6<GR<%HQ2T5&:<TKX[G5JU:_Q;V<
M>ZGM!<>V-OLMQ-OB7B7CR+VQM'H,80YJS5KJ^5*=![V)^\+9^]UWS)9P<L2[
M=)MT<+G7,LOB"4R#&E%TZ2GG6M?ET>[W#761O7O?NO=>]^Z]U[W[KW0!?)3Y
M-],?$GJO,]P]Y[OI=I;/Q+)2TX\<E;FMPYFH5S0;=VSAJ8-6YK.Y%HR(H8EL
M%#/(R1J[KL`DT'6B:=:VV^?^%/>/BW`U/UM\4*VLVVLC+!5;[[)HL1GZ^%9"
M!4+BL%A,Q1T)DB`/C-3,5/!;VYX?SZKJ^75P'\N/^:ETW_,0HMUX7;VV\WUC
MVSL6DI,KN3K;<==299ZG;U9*E'#NC;6>H(H*7,8<9$^"=&CAJ:61D\D>F1':
MC*5^SJP-?MZM&]UZWU[W[KW7O?NO=>]^Z]U[W[KW7__2VD_YKOR.K>L^K,3T
MUM6N:DW3V_'7+G:JGDT56,Z_Q[1PY1$*D2PR;DK)5HU<'F!*@>\E_NU\A0\P
M\QW/-6Y0ZMMVLKX8(P]RU2GR(B4%R/XBG6%?WS_=6?E'DZRY#V:X*;SO@?QF
M4T:.R2@D^8,[$1`_P"4=4"=0]0;T[LWE2;)V110&H^VGR><S>1D^TVYL_;=`
MODRNY]S9)@(<=A\73@LQ)URL!'&&=@/>;'-'-.T\H[5)N^\2G1J"1QJ-4L\K
M82&).+.YQZ`=S4`ZYH\C\C;_`.X._0\O\O0+XN@R2RN=,%M`F9+B>3@D4:Y/
MFQ[5!8TZ'3M&NQ76G7=!C>BERN/ZUWSELUM2M[>R-.U'O/O.NV7#1?WKR&)J
M"$J=H=4TU?EHH*/&4A1Z\ZGK'E*!5!O+L%SS!OTUQSF8WY@LXHYEL5.J#;EG
M+>"KCA/>%4+/*]1'A8@M:F1N<+FRY2Y6M[3VY6:+E/<9Y;=]SD73=;N]J%^H
M>-L-:[<KR*D4$9!F[FG9RM`5O:FTMR[XW!B]H[*V_E-S;DS%1%28O!X.BEK:
MZIEE<(I$,*D04\9-Y)I"D,2W9V4`GW(^Y[GM^SV5QNF[WT=O81*6>21@J@#/
M$\2?)15B<`$]0[LNR;MS#N=GL?+^V37>ZSL%CAA0L[$FG`<%'FS451EB!U8I
MWWUQ2?#OXQ4'0N4K*3+]\_(;/;?WGVA1XJ>.O@VMLW9L\LNV=K4IC4O/+59V
MJT^5.*J=)]`*+&3!/)6_2^ZGN'/SI;Q-%R9L4,L%HS@J9IYP!+,U>`$8K0_`
MI2N2PZRD]R>58/8KVAMO;:[N$G]R.:+F"ZW!8R'%O:VI)@MUIDEIFIJ']HXD
MTU55)ND^`?Q\F^//QXVYALW1K2[YWE(V]]\*1>:FRF7AB^PPTC$!O]P>(CA@
M93^F?RD?6_O$SWKYX3GGGF_N[.4ML]J/I[?T*(3J?_FXY9@?-=/IUGU]VKVQ
MD]K_`&OVK;]Q@"<Q7Y^KN_59)0-$1/\`PF(*A'D^OUZ.NS*BL[L%5069F(55
M51<LQ-@``.3[B4`D@`9ZG\D*"S&@'6M5WGG<E\]OEUO#&8&LJ9>JNG-E;XEQ
M];3`K#%@MEXNMJLGF(7`93/N_>,<$$+'EJ58R.%]Y^<G6=O[+^V&U7%[$HYD
MW6[MPRGB9)W4(A^4$!9F'DY/KUR=]Q-QN_O)>]V^VFVSN>3=AV^[*.O`0VL;
MM)*#ZW5T$13YQA3Y=*#^3CGVI^[NQ\)K13N'JR"O16_2T^%W!CR"!<$A$RS7
M_P`#[1?>IL@_*&PWE,0;D5_*2)O^@.C/[B>YF+W"YJV_4`;K9@X'SBF3_`)#
MT8;$_P`T#M7$_(>AZ5[,ZJV+MS'TO:2]>;HR]!E=P-7XVGDS38>++TT5:RTK
M)()89QK.@Q/>_P"?8%N?N\<MW/(LW-W+_,EY/.VW?50HR1:6(CUE"5SBC+C.
MH=2A9_>^YRLO="WY`YMY-VZUMDWGZ*XE22;7&IE\(2J&[:&JOG&DUZ%'='\P
MO?&Z_DK)T)\;M@;/W[BL94OC]P;\W/ELK0X;&MAYI#O'<1JL8WVD>TMM4PT_
M<NUZF=&6.X:/4'MN]CMGVWV_'.G/N]W5E<R+JBMH41I'UC]"*C]WC2G.D#L4
M@MP:@PWC[SW,6]>[+>VWM3RS8[E90N4FO+B21(D\(GZJ?5'VBV@7&LG]1P0E
M05J%O</\US<$V]IMB?&'K2G[*:B>HHVW/DL;N')_WBJZ+4*VJVIM3;SIE9<+
M$8V9*FHE!D3U>,+9B(N5?NUV2[0N\^XG,#;>'`;P4:)/"5OA$TTO8)#7**#0
MXU5J`#N>OOG;G)S!)RY[0\I+NQC)7ZAXYY/'9/C:VMH2)#$*$B1V!(SI`H2M
M?A]_,TR?<W9>-Z?[BV9A]I[FW)-4T.UL_MILC#BZC-4<,T[X#.8G,5%56XZO
MJA3R+#(DKH95\;HA(/LI]TON^V_*G+\_-/*N[2W.WVX#31RZ2XC8@>+&Z`*R
MBH+`@&AU`D8Z/_8W[V]YS[S;:\C<];#!9;M=LR6\T&L1M*H),,L<K,Z.U"%(
M8C4-+*I(/6KW_-W^3^[/G3\]ZCJO8N1FRNP^L]Z4G0/3V%@DD?%Y'>-;GJ;;
MV[=W&G1O%4UF8W;*U,D]M8QU%$HXO?&51I6O6;Q-3UM0];?R@OAMU?\`%7+]
M#S],[/W_`+FS>QJZEW9V3N'$TN4WYN+?53A727<6(W)71_Q+;8I\Q:3&T]')
M304:(BZ2=;,UJ-:UZMI%.J9OY._\L[YS_%SY@[;[X[EZVH>L>JL3LCL7;NZJ
M[.;[V;59>KH<MBU.*\F$PF7R<P@_B-#!/))*8TA":C]/=V8$4''K0!KT8[Y/
M_P`_C<M5W#4=$_R]>BQ\B\_05N0Q<N]:_%;JW%C]S9#&,Z9%NO-E[):+/9[!
MT!C);*5$]/3R@:HXVB*RMH)BK'K9;.!T('\N+^>!N#Y&][4_Q9^5G5.)ZB[<
MW!D,EA=EYC;=/G\7AZW=6'IZFIK]B[MVMNJ>KSNU]S2Q4<QIF,TD,LD9A=(G
M*%_,E!4<.O!J\>@0[T_X4(;^ZB^878_1U-T[UED^G>N.Y*OK_([]?+;PJMW5
M>VMO5]/0;GRE#AZ%DQU5G#/#514,`(BDF$0<@%B-A`16N>M%B#T7+?/_``I0
M^36&[,JI<=\8NOMK];4E>M3#LG?AWO2=FU>V'E,L-16YHU>+Q6/S%=CQJB,>
M,EI$D(%Y5!8^$8]>O%O08ZVFJ3Y*;1K?B@_RX@Q.:.QTZ'K>_6P3)`NX?[NX
M_8M1ONIP^DR?:G+K14S0#U^(R\WTF_MNF:5ZO7%?+K__T[)OG)O3/=X_,7LB
MCQHFRBX+/KUMM2BAO(L6.VI&::L>%0!H2?*_=U,A^OJ_/'OIE[/;38\G>U>P
MS7!$?C0?5S,<5:;*U^830@ZXI?>'W[<_<3WVYKM[0--]-<_06R#-$MQI<CY&
M3Q9&^WHP'R4V?_LD?Q5V=TEM^58.W?D5'6;B[FW32J8\D=IX*&`T^Q:68WD@
MQ*UN62F=4T^4Q5!)(EM[!/(&Z?Z[_N1NO-]\M>5]B*Q6,)RGC2$UN".!?2A<
M$UI5.&GJ3?=G8_\`@?/9K8O;[;&T\[\TAIMTN%P_T\(&FT4\1'KD$9`IJTRD
MU#]6[=8?'/X[]O\`Q9^/^U]R[*VWOW9V!V#MW);:GF$\4E%DLIB::;/UE!D,
M;4TE=25-?DWE^[5)`))`0X)7C&#F'GOGKE;W&YVW+;]WN++=IKV5)0*'4B.1
M&K*P96"I3148'PG/6;O*'M9[7<\^SGMGL^[<OVFY;%;;9!)`34%))(E,S(Z,
MKJSR%O$`85:H8$CH"^V>]?B)\",=D]I]']?;.KNZ,[&N-H-F[(I8JO+#(SD0
MXX[XW%KK<I2T8JI!HHS++5U#V5(A?R*,>6>3?<_WIGM]SYOWRZ3E.$ZVGN&*
MII&7^GB[4+4&7"A%&6;&DQUSK[C>R'W;+2\V7V\Y8L9>?K@"-+6T4-)K.(_J
MYZO(JZB*1%FE<X5!74"A_"[XX[V^3O?F9^1_R#K9=TTNS-Q+5Y0UL8?%YSL7
M'%6QNT,6B.U$<'UJ8XS51PZJ9*P14RE_'.WN4/=CGW:/;WDJUY"Y'A%M)=P:
M4TFCQVK_`!SO^+Q+O.@M1S'JD--2#J$/83VJY@]W?<J_]U?<ZX:]AL+K5)K%
M8Y;Y*>';1T.GPK"@,BK6,2Z(@6TR'K8,]X0]=-^B'?S$?D-_H%^/N9APU:M-
MOSLO[K9&SU4_Y12I64Q_O%G8P5-AAL/*VEK@K430V_PF;V,Y&_KISO:-=1:M
MEV^EQ/Z'2?THS_S4<"H\U5NL</O1>Y_^MM[97\=C<!.9-VU6EK_$NM?UYA_S
M2B)H?)W2G53?P2[Q^-'0G4O;_P#I$W96TG9O9]#D=N04%-M;.Y-,7MFAQ%;2
M8FE_BE'1S4Q?,9/(RSS*&LH2/4;@VR7]Y.3_`'`YUYFY7_<6V(W+VW.LI8S1
MIKE9U9VT,P/8BA5-,U:G6%GW<_</VE]MN2N>/ZT;W(G-V\1O`$6WFD$=ND3+
M&OB*I6LLCL["N*)7AA`?RJLH<1\N]IT+R:%S.Q=[X9Q?B1X<7392)/\`'UXO
MCV=?>1MQ=>V&YS!:F*]MW^RKE#_Q_H,_<TO#8^]^RV[/07&W7<1^9$:R#^<?
M3O\`S4]L[5P'RJKLIMO+8ZHRFZ=H[?S.[\-0LWW>"W#3))CH9L@5'CCGS6)I
M:>=0&UV4LP`924WW;]PW*]]MXK:_MI%MK:ZD2"1OADB-&(7U$;EE.*9H*T-%
M_P!\K:-FVWWDN+S:KV)KR\L89;F)/BAF4%`7\@98U1P*UQ4@5%1>VYA]H_'K
M^67N#M?8V32N[,^1,U#LK-;KBA6GR6$H\KE:S'Y/9E$_D>6"BQ.+Q5:)3Z6J
M)YS(1;QZ0O?W6Y\\_>#L>6MXM]'+^Q!IXX2:I(R(K).W`%G=XZ?PJH4?BJ-]
MJL=D]L/ND;GSGR[=B3FWFEDM);@"CPK)(R26J&I(2...75PUNY<XT4$S^3=U
MQC(Z+N+N"MIZ<U=+58K8&&JI(E+X^BIJ-=P9\T[D$Q"J:JHU<K8E8;?3V'OO
M5;]<--RMRM"[>$RO<N`?B8MX4=1YZ:.1\VZ%OW$>5;-;?GKGFXB7QT>.SB8C
M*(J^--0^6K5$#3R6G59NW=R39CY8[@[#VXY@_AW8':W:..FIQH,-%M2BW?O*
M.=-(LH-/B@?Z>KW-/.6GE_V1W2"]%7AV*.$@YJ[1QQ@?[T?Y=8V>W.KFW[S.
MQ76V8CN>:9;A2,4B6:68G[-"_P`^JF/Y1NU%[>_F5?%[^.LM:?\`2%G.TLJ:
MM1,*W(;9V]N'>B/,'!$DLF<ABD)/]H7]\V&PAZ[2<6_/J\G^='V1_-'ZS[OW
M?VE\?MP=U=7?$GK;K/94&<WIM7<6SL7LZHW'65]8^:S+T%96R[AJ*D5F:H\>
M2M,Q9XAI4KS[H@6F>/6VK7'#JK_JK^83\RZ_X:?.3?G:GR*[.[`I\[@^KOCE
MU]3;ES,,L.%W1VYFLUDMYY_%_;8^F*9*BZYVQ54P?5J1:ZXL?=BHU+CK0)H<
M](S^5'W_`/(+XEY+LSMGH;X/;C^4=?N>CQ6P!O3%4.ZS2;#I,4?XOE=M8^NV
M]MK/0I59LU5'-5(6BD$<$(-U(][8`X)Z\*C@.A/ZNV7\O.T?YI&S?F;VA\5.
MVNG<%5=T_P"FS>LM9L3<]+M+96#V3M*MRV0^[W!EL5CXI(&HMO:7GF6,S336
M(NUO>B0%TUZ]FM:=`]_*3V#2?++^:%UUG]]8VFW#C&W/V3\B=T464IEK**KK
ML8:_<F'-?!(#%,L.[LW0NJN"ADC6X(X][<T7'7AD]"5_/RW9%VA_,JW#LO#+
M!)/L_8'5'5BR01JLD^;S:56>DBG95#2ST\^\8H06N0%`'``]^C';UYN/6Z=%
MT31P?$8_&F*.".C;X[S=*%5-J<I4=<OLJ9[W_P`W(TC,3?\`/MFN:].>5.O_
MU+Q_CCU#2K\G^U-T[YI/W(?EQ0]54SUH*QI5Y+)[S[(KU+2C3Y<HFU\92)R#
M)%5.@OKYSMY^YHD;V[Y:VW9Y>T\L->$+QTHL%JO#R3QIG/H4!/#KEE[5<CPK
M[O\`.6\<Q0]Z\[IMRE^`:22ZOWR<5D%O;QCS*R,HKJZ-[_,Y^'_:O?M7L#L7
MJ7'0;FRNT,/EMNY[:C9"GH,E4XZKK8<E09+"FNDAHZN>&H\L<\+21NRLC)JL
MP]QA]WKW2Y;Y*CWO8N9IVM[:ZE26.;260,JE&632"P!&DJP!%00:5'4X?>Z]
MC.<O<J?EGFGDFU6[O+&"2":VUJDC(SB1'BUD*Q#:@R%E)!4K6A'59VQOAK\Y
MX,35XR>?<?277\+>7-U^]>TYMD[/H:>9PE34S8S%YFJ>?4&)*QT]Y2;7N;^\
M@=Y]U_9Q[J*Y1(-WWPXC6"S%Q.Q`P`[H`/M+8ZQ)Y=]AOO%1V4UG))=<O\LJ
M:RO=[@;2U0$T9C''*Q/V!.[AT8/XX_"_'[UW-6X;K/+YC+;>I931]H_)O.82
M;#-4PR.RY'97QYP=>)ZJBRV3B5XJ_<U7*]93T[VAC@9PK@;GSW9GVK;XKOF"
MUBBOF&JTVF.0.`1\-QN<BT#(AH8[1`(V8=S.!42A[5>P=KO^[SV'*5[//MB'
M3N&_S1&+4">^TV6)ZLLD@JLU_(QE1#1%C+`-?WLS9NV.O=K8+96S<-1X#;&V
M\=3XO#XF@B$5/24E.NE1QZI9I6N\LCEI)9&9W)9B3A3NVZ[AOFXWF[;K=//N
M%PY=W8U+,?\``!P`&`````!UTLV'8=HY8V?;M@V&PCMMHM(A'%&@HJJO^$GB
MS&K,Q+,223TIB0H+,0%`)))L`!R22>``/9?QP./1L2`"2<=:QWRFW_E/G#\U
M]N=6;)J_O-IX3<D76>UIJ283TQQ]+7BHW_O4:-<0B<4L[)+8@T])#<\^^A'M
MSLMO[/\`M)?\R;O%HW.:W-W,&%#J9:6T&<U[EJ/XG;TZY&^\7,MY]X;[P&U<
MG<OSZ]EM[L6%N5-5T*^J]NL5%.URK>:1IG/5DU1_*-^*T5-/)'7=LM-'3RLA
M;?%/I,J1,59E&!`L7%R!_K>X$C^\[[CM(BM#MFDL/^(YX5_YJ=972_<C]FTA
MD9+C>BX4T_QM>-/^:/KU07TYVQ7_`![[CQW8V%IJ7)Y78]9NVAH:*LJ1#32U
M-1CLQMZGEK&4,SPTDU0LTB"WE$96ZWN,U.:N68>>.59]ANY&CMKQ(69E%2`&
M24A?0L`5!\JUS3KFMR+SK<^V'/=KS380I->[?)<HB,U%+,DL*EJ<0I8,P_%I
MTXK4&EJ_B)V5O#XK=H?,?LG)YJIWGE,OCMXX:ARC5'\1S.T9LH8=U;JS,-3$
M9U&06LCEQT894AH:8O;0\8$;Q^Y^P;7[C\N>U7+]O"NT11-!(R4TI,$K##&0
M:=NDB4T):1Z<0U9CF]D.;-]]F^;_`'VYKN[A]^FG2ZB235KEMC)2XN)0PKWZ
M@T"U`6*,M\++1`;#S&;[)^&G:?4>%2IS&3ZC[-VWW?28BA\E;7S[*S./K=K;
MNJ*.A@,M1/3[?RDM-5S"-"(XIY)&X%_9WO-K9[![K\N<SW96*WW3;Y=O9VHJ
MBXC99H`S&@!E0,@J<E5`Z#/+=]N'-GL-SER1MZM/>;)N\&[+$E6<VDJ/;W+*
M@J2(9#'*VD4579CT)OQL^=F&^/7QE[.ZAH-IY');^W;FMPUVV]Q0UE##@Z(;
MEP6.PC564)F7(_=84T9DACBC<3$J"R6/L/\`/WLW=\\^X/+W-$VYQQ[);11+
M+$58R-X4C243&FDFJC$D:<FAZ%OM/]XS;_;#VDYNY'MMEEEYEOKB=X)PR"%/
M'A2+5)G7JBT:E55(>H%5ST8C^6C\,,MN;%;X[=[*Q>3P6!W+L3=76>PJ3*44
MU+D,E2;RP\V%W/O!:2LCAF^Q7&5+4M'(;"H,DS`Z0"T;?>6]R+&>TBY"V>Z2
M65I5ENV1@RIH),<-5)&K5WN/PT0')-)H^Y=[-[I:[C<>ZO,5C+!;I"T%@DJE
M7D,@`EN=+`'1I_3C;\>J0C`%=5*&#OS^53\V<179;;RX?LSH/>M=/A(-Q4M;
M!M?L39U1%78A*W'UJ?;'*;7WEM6M8"HI79J>20@VEB9/>'F&'71C@>K!_EK_
M`#+_`)8?S;]IQ?'WJ/H=-C]=;;H\AV=VC2;;S63W8E=2;!Q5=N)\CO7>LN(P
MF%VUM'#0T;U$-')%Y:VN6$:Y&6-!4*%R3UXDGRZ3W6GQ*WSV?_(GWOVIU]@\
MAN++4'R^G[HR&)Q5#-6Y3*];;&VE#UODZ[&TM+'+5Y'^"5-?55CQQJY6"&9^
M-)]^U`/3Y=>IV]/W\M3^<CL#X"?$OLOI:KZHW#O7LO*;^W3OO8>:QN5PE%M2
MKK]S8/"8NEIMWRU=0,K11X&MPRNPIX*DU4#>-?$XO[\R%C7KP-!T-_17:?\`
M,)J/@1\WOF5\J.^>W*CJ/(=.;JZUZ9Z^[`JWQD.]M[=J9.@VO/O+%T.3QE-E
M8MI;8ILZ:?$Z)A'5R/(4U1T]W\0NI0!UO-":]*+_`(3']7T^2[9^2_<LD2RP
M;+V'L[K;%UGI:*"KW;E:S<.519.0DGV.V*;4`?TMS^/>I#P'7EZK=VE7K\S?
MYSF+K'F&0H.R?FK4932I2KMLSK_=53707C4NII8ML;+3_:`I_I[MP3\NM<3U
MO'?[-9A3WRW2@VCE_$F47`-NDU""+^-LH7PIC!3$&D%0X4DU`J/"?N/#X+.6
M:8KU>O7_U=P3N+"_%3)X?O6FW-N_([=J,MV;UA2;RR.T:#<57N#:_>\=%AUZ
M[RNTXL)@LI65N]IJ:3',\5'%6)IC`G5+RWF?E6[]R+>ZY-DV_:XYXXMONV@6
M=HEBFV[4_P!4DQDD15MP1*`7*'/831>L;^>[#V:N[#W%AW;?);66;=]O6ZDM
MDG:>WW<)%]#);"&&1GNRI@)6-911?U`*OTN,)UU\OJ&GAQTWR4V)F<0L2"GS
MF7Z)\&^)*;0/$:U*?>V-V_\`Q+QVUN]`HUW+1WNOLGN]]]KYG>=.0+R*ZJ:Q
MIN-;>OGIK;O+IKP`D..#>?0AV_E;WPMHH[63W7VZXL0HI-+M%+LK3&O3=QP>
M)3B3",Y*>70*;ZV7UCB]TT,ORD[AW]N1H99:C!T>X]M[KHL#6,%M74F+J]M[
M.Q>QZ9FC(+18N,Y18@=58T>H>Q9L^[<PW.W3+[=\K65N"`)#%+"TB_PLXEG>
MX.>!F(A+4I$&IT`.8M@Y1L]YMW]X.>MSNRI+1+/!<I"Q_&L;06L=HN.*VZ_4
M!:UG*UZL$VC_`'5_NQ@_[D?P;^Z/\.I_[O\`]WOM?X+_``S1_D_\.^R_R;[?
M3_J?S>_-_<);G^\?WA>?O?Q?WGXA\7Q:^)K\]6K-?MZR9V3]S?NC;OZO>!^Y
M/"7P?`T^%X=.W1H[=/V>?SZ4?M#T:]<)?'XY/-H\.A_+Y=/C\>DZ_)K].C3>
M]^+>]KJU+IKJKBG&ORZJ^G2VNFBF:\*>=?ET%FU?]!_\:@_N1_HI_O%XJG[;
M^ZO]T?XUX/&?O/!_"/\`+O%XK^73QI_5Q[$>Y?UO^D?][_O+Z&HKXWC^'6O;
M77VUKPKY\.@=LW^M[]?'_5[]S?O32VGZ?Z;Q:4[J>%WTI\5,4X]"J;6-[6MS
M?Z6_-_\`#V&^AGT!DW^RT>6;[C_07Y_++]QYO[@>7SZV\_FU^OR^2^O5SJO?
MGV,4_K_I3P_WQHH*4^II3RI3RIPZCJ3_`%I=<GB_U=\2IU5^CK6N:US6M:US
M7CT+E;_=_P#@,_\`$?X/_=C^&G[G[W[+^`_P?P"_G\_^X_\`AOVO^J_:\?\`
MA[#$/UOUB>!XO[P\3&G5XFNOE3NU5],U^?0VN/W9^[9/J_`_='A=VO1X/A4\
MZ]GAZ?7MI\ND-M/_`$+?Q*7^XO\`HN_B_P!C/Y_[I_W3_B7\-U1?<^7^#_Y5
M]CKT>2_[=]-_Q[.-S_K;X"_OC]X_2ZQ3QO&TZ\TIKQJXT\^-.@]LO]0/JW_J
M[^Y_K_#-?IOIO$\/&JOA=VBM*U[>%?+H(H?]DG_ON?!_LMO]_?N1_F_]'?\`
M&_O_`"<:;?N?Q#S?T_>U_P"/L3M_KM?NCO\`W_\`N;3Y_5>'II^S33_:T^70
M(3_@?_ZP?I_U4_K)K\OH?%UU_;KK_MJ_/HUBZ=*Z-.C2-&FVG3;TZ;<:;?2W
MN-S6IKQZF84H-/P]%M^1_P#LH_\``J#_`&:[_0)_`M4G\(_TW_W&\&O4OF_@
MW]\/W/)>VO[;G^OOPKY=;Z=.E?\`97?]'>1_V7W_`$'?Z+?#4_QK_13_`''_
M`+F>'[-_O?XY_=C_`'%7^PU>;[KU>*^OT^_9_/KV/+H2]A?Z.O[IT/\`HP_N
M5_<;_*_X9_<+^!_W3_X$2_??8_W>_P!P_P#P*U^7Q_[LU:N;^]=>Z);/_P`-
M<?Z5F^X_V2+_`$P?Q#]SR_Z%_P"]O\8\W^[-7^4_QK[G^O\`E/D_VKWON^?6
ML='-WW_HS_NG+_I-_N+_`'&UT'G_`+]_P#^Z?D\L?\,\O]X/]P^OS:?!?G5;
M1S;WKK?3-UE_H2_A^9_T-_Z+/X5]S#_>#_1E_=+^'_>?;MX/XS_=;_)ON?M+
MZ//ZO'>W'OW6L>72+V9_LI_][*#_`$>?[+Q_?KRUO\,_N9_HV_O9Y_!/_$?L
M/X'_`+F/+]KY?/X^?'JU<7][SUO'2V/^A_\`TH)J_N3_`*7/X:=%_P"&?WN^
9P^U-]-_\L\O\-O>W[WVG_-KW[-/EU[K_V3\_
`
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
